Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study-Reference-Cited by-同舟云学术

Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study

Published:2020-03 Issue:2 Volume:39 Page:
ISSN:0392-9590
Container-title:International Angiology
language:
Short-container-title:Int Angiol

Author:

Kakkos Stavros K.,Arnaoutoglou Eleni,Tsolakis Ioannis A.,Giannoukas Athanasios,Papadimitriou Christos A.,Kentepozidis Nikolaos,Boukovinas Ioannis,Kalofonos Haralabos P.,Labropoulos Nicos,Matsagkas Miltiadis

Publisher

Edizioni Minerva Medica

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R34Y2020N02A0112

Reference26 articles.

1. Development and validation of a predictive model for chemotherapy-associated thrombosis

2. FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

3. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

4. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer

5. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis;Diagnostics;2022-11-25

2. Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies;International Journal of General Medicine;2021-07

3. Risk of thromboembolism in patients with ALK‐ and EGFR‐mutant lung cancer: A cohort study;Journal of Thrombosis and Haemostasis;2021-01-24

4. IS HIGH-DENSITY LIPOPROTEIN A PREVENTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH LUNG CANCER;ACTA MEDICA MEDITERR;2021